@article{barrera-gomezOptimalCombinationNumber2013,
  title = {Optimal Combination of Number of Participants and Number of Repeated Measurements in Longitudinal Studies with Time-Varying Exposure},
  author = {{Barrera-G{\'o}mez}, Jose and Spiegelman, Donna and Basaga{\~n}a, Xavier},
  year = {2013},
  journal = {Statistics in Medicine},
  volume = {32},
  number = {27},
  pages = {4748--4762},
  issn = {1097-0258},
  doi = {10.1002/sim.5870},
  urldate = {2022-12-05},
  abstract = {In the context of observational longitudinal studies, we explored the values of the number of participants and the number of repeated measurements that maximize the power to detect the hypothesized effect, given the total cost of the study. We considered two different models, one that assumes a transient effect of exposure and one that assumes a cumulative effect. Results were derived for a continuous response variable, whose covariance structure was assumed to be damped exponential, and a binary time-varying exposure. Under certain assumptions, we derived simple formulas for the approximate solution to the problem in the particular case in which the response covariance structure is assumed to be compound symmetry. Results showed the importance of the exposure intraclass correlation in determining the optimal combination of the number of participants and the number of repeated measurements, and therefore the optimized power. Thus, incorrectly assuming a time-invariant exposure leads to inefficient designs. We also analyzed the sensitivity of results to dropout, mis-specification of the response correlation structure, allowing a time-varying exposure prevalence and potential confounding impact. We illustrated some of these results in a real study. In addition, we provide software to perform all the calculations required to explore the combination of the number of participants and the number of repeated measurements. Copyright \textcopyright{} 2013 John Wiley \& Sons, Ltd.},
  langid = {english},
  keywords = {intraclass correlation,longitudinal study,optimal design,sample size},
  file = {/Users/zenn/Zotero/storage/SFMMF7FA/Barrera-GÃ³mez et al. - 2013 - Optimal combination of number of participants and .pdf;/Users/zenn/Zotero/storage/5ZRCFGXS/sim.html}
}

@article{ghoshStatisticalPowerSample2022,
  title = {Statistical Power and Sample Size Requirements to Detect an Intervention by Time Interaction in Four-level Longitudinal Cluster Randomized Trials},
  author = {Ghosh, Samiran and Mukhopadhyay, Siuli and Majumder, Priyanka and Wang, Bo},
  year = {2022},
  month = jun,
  journal = {Statistics in Medicine},
  volume = {41},
  number = {14},
  pages = {2542--2556},
  issn = {0277-6715, 1097-0258},
  doi = {10.1002/sim.9369},
  urldate = {2022-11-04},
  langid = {english},
  file = {/Users/zenn/Zotero/storage/RCDGKD7S/Ghosh et al. - 2022 - Statistical power and sample size requirements to .pdf}
}

@article{heoSampleSizeRequirement2010,
  title = {Sample Size Requirement to Detect an Intervention Effect at the End of Follow-up in a Longitudinal Cluster Randomized Trial},
  author = {Heo, Moonseong and Kim, Yongman and Xue, Xiaonan and Kim, Mimi Y.},
  year = {2010},
  month = feb,
  journal = {Statistics in Medicine},
  volume = {29},
  number = {3},
  pages = {382--390},
  issn = {02776715},
  doi = {10.1002/sim.3806},
  urldate = {2022-11-04},
  langid = {english},
  file = {/Users/zenn/Zotero/storage/BHJ4IKKQ/Heo et al. - 2010 - Sample size requirement to detect an intervention .pdf}
}

@article{winkensOptimalNumberRepeated2006,
  title = {Optimal Number of Repeated Measures and Group Sizes in Clinical Trials with Linearly Divergent Treatment Effects},
  author = {Winkens, Bjorn and Schouten, Hubert J. A. and {van Breukelen}, Gerard J. P. and Berger, Martijn P. F.},
  year = {2006},
  month = feb,
  journal = {Contemporary Clinical Trials},
  volume = {27},
  number = {1},
  pages = {57--69},
  issn = {1551-7144},
  doi = {10.1016/j.cct.2005.09.005},
  urldate = {2023-04-15},
  abstract = {The effect of number of repeated measures on the variance of the generalized least squares (GLS) treatment effect estimator is considered assuming a linearly divergent treatment effect, equidistant time-points and either a fixed number of subjects or a fixed study budget. The optimal combination of group sizes and number of repeated measures is calculated by minimizing this variance subject to a linear cost function. For a fixed number of subjects, the variance of the GLS treatment effect estimator can be decreased by adding intermediate measures per subject. This decrease is relatively large if a) the covariance structure is compound symmetric or b) the structure approaches compound symmetry and the correlation between two repeated measures does not exceed 0.80, or c) the correlation between two repeated measures does not exceed 0.60 if the time-lag goes to zero. In case the sample sizes and number of repeated measures are limited by budget constraints and the covariance structure includes a first-order auto-regression part, two repeated measures per subject yield highly efficient treatment effect estimators. Otherwise, it is more efficient to have more than two repeated measures. If the covariance structure is unknown, the optimal design based on a first-order auto-regressive structure with measurement error is preferable in terms of robustness against misspecification of the covariance structure. The numerical results are illustrated by three examples.},
  langid = {english},
  keywords = {Cost function,Generalized least squares,Group sizes,Linear divergence,Number of repeated measures},
  file = {/Users/zenn/Zotero/storage/2YI8Y7TM/Winkens et al. - 2006 - Optimal number of repeated measures and group size.pdf}
}

@article{winkensOptimalTimepointsClinical2005,
  title = {Optimal Time-Points in Clinical Trials with Linearly Divergent Treatment Effects},
  author = {Winkens, Bjorn and Schouten, Hubert J. A. and {van Breukelen}, Gerard J. P. and Berger, Martijn P. F.},
  year = {2005},
  journal = {Statistics in Medicine},
  volume = {24},
  number = {24},
  pages = {3743--3756},
  issn = {1097-0258},
  doi = {10.1002/sim.2385},
  urldate = {2023-04-15},
  abstract = {In repeated measures studies, equidistant time-points do not always yield efficient treatment effect estimators. In the present paper, the optimal allocation of time-points is calculated for a small number of repeated measures, different covariance structures and linearly divergent treatment effects. The gain in efficiency of the treatment effect estimator by using optimally allocated time-points instead of equidistant time-points or by adding optimally spaced measures (at the expense of patients) is then computed. The assumed covariance structure is crucial for the results. For a compound symmetric covariance structure, a large gain in efficiency is obtained by adding repeated measures at the end of the study. For a first-order auto-regressive covariance structure, highly efficient treatment effect estimators are obtained with only two repeated measures, i.e. at the start and at the end of the study. For a first-order auto-regressive covariance structure including measurement error, the gain in efficiency by adding optimally spaced measures depends on the covariance parameter values. The gain in efficiency is similar with or without a random intercept. For a fixed study budget, the commonly used design with more than two equally spaced measures was never optimal for the linear cost function and covariance structures that were used. If the covariance structure is unknown, the optimal design based on a first-order auto-regressive covariance structure with measurement error is preferable in terms of robustness against misspecification of the covariance structure. The numerical results are illustrated by two examples. Copyright \textcopyright{} 2005 John Wiley \& Sons, Ltd.},
  langid = {english},
  keywords = {allocation of time-points,compound symmetry,first-order auto-regression,linear divergence,repeated measures},
  file = {/Users/zenn/Zotero/storage/JXMJMLSX/sim.html}
}

@article{winkensOptimalTimepointsClinical2005a,
  title = {Optimal Time-Points in Clinical Trials with Linearly Divergent Treatment Effects},
  author = {Winkens, Bjorn and Schouten, Hubert J. A. and {van Breukelen}, Gerard J. P. and Berger, Martijn P. F.},
  year = {2005},
  month = dec,
  journal = {Statistics in Medicine},
  volume = {24},
  number = {24},
  pages = {3743--3756},
  issn = {0277-6715, 1097-0258},
  doi = {10.1002/sim.2385},
  urldate = {2023-04-15},
  abstract = {In repeated measures studies, equidistant time-points do not always yield e cient treatment e ect estimators. In the present paper, the optimal allocation of time-points is calculated for a small number of repeated measures, di erent covariance structures and linearly divergent treatment e ects. The gain in e ciency of the treatment e ect estimator by using optimally allocated time-points instead of equidistant time-points or by adding optimally spaced measures (at the expense of patients) is then computed. The assumed covariance structure is crucial for the results. For a compound symmetric covariance structure, a large gain in e ciency is obtained by adding repeated measures at the end of the study. For a \"yrst-order auto-regressive covariance structure, highly e cient treatment e ect estimators are obtained with only two repeated measures, i.e. at the start and at the end of the study. For a \"yrst-order auto-regressive covariance structure including measurement error, the gain in e ciency by adding optimally spaced measures depends on the covariance parameter values. The gain in e ciency is similar with or without a random intercept. For a \"yxed study budget, the commonly used design with more than two equally spaced measures was never optimal for the linear cost function and covariance structures that were used. If the covariance structure is unknown, the optimal design based on a \"yrst-order auto-regressive covariance structure with measurement error is preferable in terms of robustness against misspeci\"ycation of the covariance structure. The numerical results are illustrated by two examples. Copyright ? 2005 John Wiley \& Sons, Ltd.},
  langid = {english},
  file = {/Users/zenn/Zotero/storage/ANH3MW9H/Winkens et al. - 2005 - Optimal time-points in clinical trials with linear.pdf}
}
